The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

28 Apr 2010 07:03

RNS Number : 9200K
iShares II $ S&P Listed Priv Eqty
28 April 2010
 

FUND:

iShares S&P Listed Private Equity

DEALING DATE:

26-Apr-10

NAV PER SHARE:

Official NAV USD 13.8561

GBP (Equivalent) 9.0309

EUR (Equivalent) 10.4056

NUMBER OF UNITS IN ISSUE:

8,500,000

CODE:

IDPE LN

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVPGUMACUPUPWM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.